These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17638888)

  • 1. Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis.
    Loomis KD; Zhu S; Yoon K; Johnson PF; Smart RC
    Cancer Res; 2007 Jul; 67(14):6768-76. PubMed ID: 17638888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
    Shim M; Powers KL; Ewing SJ; Zhu S; Smart RC
    Cancer Res; 2005 Feb; 65(3):861-7. PubMed ID: 15705884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
    Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.
    Shi YC; Zhao H; Yin C; Zeng X; Zhang Q; Xu WP; Wei J; Chen F; Xie WF
    Dig Liver Dis; 2013 Oct; 45(10):844-51. PubMed ID: 23816696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C/EBPalpha and beta couple interfollicular keratinocyte proliferation arrest to commitment and terminal differentiation.
    Lopez RG; Garcia-Silva S; Moore SJ; Bereshchenko O; Martinez-Cruz AB; Ermakova O; Kurz E; Paramio JM; Nerlov C
    Nat Cell Biol; 2009 Oct; 11(10):1181-90. PubMed ID: 19749746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.
    Sato A; Yamada N; Ogawa Y; Ikegami M
    PLoS One; 2013; 8(2):e57013. PubMed ID: 23437297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
    Togami K; Kitaura J; Uchida T; Inoue D; Nishimura K; Kawabata KC; Nagase R; Horikawa S; Izawa K; Fukuyama T; Nakahara F; Oki T; Harada Y; Harada H; Aburatani H; Kitamura T
    Exp Hematol; 2015 Apr; 43(4):300-8.e1. PubMed ID: 25534203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes.
    Yoon K; Smart RC
    Mol Cell Biol; 2004 Dec; 24(24):10650-60. PubMed ID: 15572670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C/EBPalpha and C/EBPbeta are required for Sebocyte differentiation and stratified squamous differentiation in adult mouse skin.
    House JS; Zhu S; Ranjan R; Linder K; Smart RC
    PLoS One; 2010 Mar; 5(3):e9837. PubMed ID: 20352127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CCAAT/enhancer binding proteins (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms.
    Oh HS; Smart RC
    J Invest Dermatol; 1998 Jun; 110(6):939-45. PubMed ID: 9620302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction.
    Rangatia J; Vangala RK; Singh SM; Peer Zada AA; Elsässer A; Kohlmann A; Haferlach T; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Jul; 22(30):4760-4. PubMed ID: 12879022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia.
    Hughes JM; Legnini I; Salvatori B; Masciarelli S; Marchioni M; Fazi F; Morlando M; Bozzoni I; Fatica A
    Oncotarget; 2015 Jul; 6(21):18534-44. PubMed ID: 26053097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias.
    Gombart AF; Hofmann WK; Kawano S; Takeuchi S; Krug U; Kwok SH; Larsen RJ; Asou H; Miller CW; Hoelzer D; Koeffler HP
    Blood; 2002 Feb; 99(4):1332-40. PubMed ID: 11830484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
    Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
    Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer.
    Halmos B; Huettner CS; Kocher O; Ferenczi K; Karp DD; Tenen DG
    Cancer Res; 2002 Jan; 62(2):528-34. PubMed ID: 11809705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.
    Zhu S; Yoon K; Sterneck E; Johnson PF; Smart RC
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):207-12. PubMed ID: 11756662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models.
    Kato N; Kitaura J; Doki N; Komeno Y; Watanabe-Okochi N; Togami K; Nakahara F; Oki T; Enomoto Y; Fukuchi Y; Nakajima H; Harada Y; Harada H; Kitamura T
    Blood; 2011 Jan; 117(1):221-33. PubMed ID: 20884804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
    Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
    Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.